Despite GCs’ antitumor effects in hematopoietic malignancies, a recent meta-analysis study on the significance of GR expression in cancer found that high GR expression was linked to cancer progression and a worse prognosis in certain solid tumors, including endometrial, ovarian, and early stages of untreated triple-negative breast cancers [63]. Here, NR3C1 is linked to cancer.